MicroWash logo — Painless, fast and easy collection of COVID-19 nasal specime...

MicroWash

Painless, fast and easy collection of COVID-19 nasal specimens and other respiratory illnesses

Founded 2022 United States Omaha, United States 2-10 employees Seed Total: $1.70M Health Care

General Information

Company Name MicroWash
Founded Year 2022
Location United States Omaha, United States +1
Employees 2-10
Industries Health Care
Funding Stage Seed
Social

Get notified when MicroWash moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MicroWash

MicroWash is a health care startup revolutionizing the sampling experience for respiratory illness diagnosis. Their slogan "Painless, fast and easy collection of COVID-19 nasal specimens and other respiratory illnesses" encapsulates their mission. The company's flagship product, the first nasal specimen collection device, aims to set a new gold standard for respiratory infection nasal sampling. Notably, it boasts surpassing the nasal swab in comfort, accuracy, stability, and accessibility. Founded in 2022 and headquartered in the United States, MicroWash recently received a $1.60MSeed Round investment on 20 February 2024 from prominent investors including Invest Nebraska, Bright Minds Capital Partners, Craig Aman, Anne Bueltel, Karen Aman, and Nicholas Lorenzo.

MicroWash has the potential to transform respiratory illness diagnostics and patient experience in a post-pandemic world. With its experienced leadership from diverse medical backgrounds and significant investments, the company is well-positioned to propel the evolution of specimen collection systems. As the demand for innovative and patient-friendly healthcare solutions continues to grow, MicroWash is poised to make a significant impact and attract further interest from both the industry and potential investors.

Taxonomy: respiratory illnesses, specimen collection, diagnostics, nasal sampling, patient experience, pandemic response, university medical devices, nasopharyngeal irrigation, precision medicine, global health crisis, telehealth, primary care

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 6
Investor Investor
•••• ••••
20 Feb 2024
Pre Seed Round •••••• 1
Investor
20 Oct 2022
Pre Seed Round •••••• - 20 Oct 2022

MicroWash Alternatives & Competitors

MicroWash vs
NasoNeb®
NasoNeb® United States

Breaking down barriers to wellness while helping people feel better and breathe better.

3 employees
Health Care, Medical Devices
MicroWash vs

SPECIALIZING IN EYE HEALTH CARE

55 employees
Manufacturing
MicroWash vs

Mobile Biospecimen Collection Services For The Medical Community

15 employees

FAQ About MicroWash

Painless, fast and easy collection of COVID-19 nasal specimens and other respiratory illnesses
MicroWash was founded in 2022.
MicroWash is headquartered in Omaha, United States.
MicroWash operates in the following industries: Health Care.
MicroWash has approximately 2-10 employees.
MicroWash has completed 3 funding rounds, raising a total of $1.70M. The latest funding stage is Seed.
Top alternatives and competitors to MicroWash include NasoNeb®, Pharma Stulln, MediPro Direct, Inc., MSI Health Solutions, LLC, Hans Rudolph, inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MicroWash and NasoNeb® are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MicroWash and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy